Sains Malaysiana 46(9)(2017): 1499–1503

http://dx.doi.org/10.17576/jsm-2017-4609-19

 

Role of Cytochrome P450 Monooxygenase in the Bioactivation of Aflatoxin B1

(Peranan Sitokrom P450 Monooksigenase dalam Biopengaktifan Aflatoksin B1)

 

SUREEPORN NUALKAEW, HIRUN SAELIM, DANAI TIWAWECH, TANATE PANRAT IMRAN PARVEZ & AMORNRAT PHONGDARA*

 

Center for Genomics and Bioinformatics Research, Department of Molecular Biotechnology

and Bioinformatics, Faculty of Science, Prince of Songkla University, Hatyai,

Songkhla 90112, Thailand

 

Received: 31 August 2016/Accepted: 17 January 2017

 

ABSTRACT

In a previous study, the gene EgP450 that encodes the proteins of 505 amino acids was isolated from oil palm. The recombinant protein EgP450 is bound to phenylurea-like herbicides which detoxify the substance. Aflatoxin B1 (AFB1), a mycotoxin produced by Aspergillus sp., is another toxic compound that is known to cause acute toxic effects and act as a hepatocarcinogenic agent. This study aimed to examine the role of EgP450 enzyme in mycotoxin bioactivation in human mesenchymal stem cells (hMSCs). Docking analysis showed that EgP450 is bound to the group of carcinogens, which includes AFB1, n-(2-fluorenyl) acetamide, n-n-butyl-n-butan-4-ol-nitrosamine, n-nitrosodiethylamine, n-nitrosodiethylamine and n-nitrosodimethylamine. An in vivo aflatoxin toxicity test on hMSCs and AFB1 induces the expression of Bmi-1 which is one of the markers for the development of cancer. The presence of EgP450 at 0.15 μg/mL could reduced the Bmi-1 expression in AFB1 induced cells. Moreover, this protein also showed some antioxidant activity. These results exhibited the enormous potential of EgP450 in the detoxification processes.

 

Keywords: Carcinogen; cytochrome P450 monooxygenase; detoxification

 

ABSTRAK

Dalam kajian sebelum ini, gen EgP450 yang mengekod 505 protein asid amino telah dipencilkan daripada kelapa sawit. Protein rekombinan EgP450 terikat kepada racun herba seperti phenylurea yang menyahtoksin bahan. Aflatoksin B1 (AFB1), mikotoksin yang dihasilkan oleh Aspergillus sp., adalah satu lagi toksik sebatian yang diketahui menyebabkan kesan toksik akut dan bertindak sebagai agen hepatokarsinogen. Kajian ini bertujuan untuk meneliti peranan enzim EgP450 dalam biopengaktifan mikotoksin sel stem mesenkim manusia (hMSCs). Analisis dok menunjukkan bahawa EgP450 terikat kepada kumpulan karsinogen, termasuk AFB1, n-(2-fluorenil) asetamid, n-n-butil-n-butan-4-ol-nitrosamin, n-nitrosodietilamin, n-nitrosodietilamin dan n-nitrosodimetilamin. Ujian in vivo ketoksikan aflatoksin ke atas hMSCs dan AFB1 mengaruh ekspresi Bmi-1 yang merupakan salah satu penanda bagi pembangunan kanser. Kehadiran EgP450 pada 0.15 μg/mL boleh mengurangkan ekspresi Bmi-1 dalam sel aruhan AFB1. Selain itu, protein ini juga menunjukkan beberapa aktiviti antioksidan. Keputusan ini menunjukkan potensi besar EgP450 dalam proses penyahtoksikan.

 

Kata kunci: Karsinogen; penyahtoksikan; sitokrom P450 monooksigenase

 

REFERENCES

 

Aoyama, T., Yamano, S., Guzelian, E.S., Gelhoin, H.V. & Gonzales, E.J. 1990. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proceedings of the National Academy of Sciences 87: 4790-4793.

Bulatao-Jayme, J., Almero, E.M., Castro, M.C., Jardeleza, M.T. & Salamat, L.A. 1982. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. International Journal of Epidemiology 11(2): 112-119.

Crespi, C.L., Penman, B.W., Steimel, D.T., Gelboin, H.V. & Gonzalez, E.J. 1991. The development of a human cell line stably expressing human CYP3A4: Role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis 12(2): 255-259.

Gallagher, E.P., Kunze, K.L., Stapleton, P.L. & Eaton, D.L. 1996. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicology and Applied Pharmacology 141(2): 595-606.

Gallagher, E.P., Wienkers, L.C., Stapleton, P.L., Kunze, K.L. & Eaton, D.L. 1994. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer Research 54(1): 101-108.

Groopman, D., Cain, L.G. & Kensler, T. 1988. Aflatoxin exposure in human populations: Measurements and relationship to cancer. Critical Reviews in Toxicology 19(2): 113-143.

Guengerich, F.P., Johnson, W.W., Shimada, T., Ueng, Y.F., Yamazaki, H. & Langouët, S. 1998. Activation and detoxication of aflatoxin B1. Mutation Research 402(1&2): 121-128.

He, X.Y., Tang, L., Wang, S.L., Cai, Q.S., Wang, J.S. & Hong, J.Y. 2006. Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract. International Journal of Cancer 118(11): 2665-2671.

Huey, R., Morris, G.M., Olson, A.J. & Goodsell, D.S. 2007. A semiempirical free energy force field with charge-based desolvation. Journal of Computational Chemistry 28(6): 1145-1152.

Kensler, T.W., Roebuck, B.D., Wogan, G.N. & Groopman, J.D. 2011. Aflatoxin: A 50-year odyssey of mechanistic and translational toxicology. Toxicological Sciences 120(S1): S28-S48.

Lee, P.H., Kuo, K.L., Chu, P.Y., Liu, E.M. & Lin, J.H. 2009. SLITHER: A web server for generating contiguous conformations of substrate molecules entering into deep active sites of proteins or migrating through channels in membrane transporters. Nucleic Acids Research 37: W559-W564.

Livak, K.J. & Schmittgen, T.D. 2001. Analysis of relative gene expression data using real- time quantitative PCR and the 2-ΔΔCT. Methods 25(4): 402-408.

Mihara, K., Chowdhury, M., Nakaju, N., Hidani, S., Ihara, A., Hyodo, H., Yasunaga, S., Takihara, Y. & Kimura, A. 2006. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and prognosis of the patients. Blood 107(1): 305-308.

Morris, G.M., Goodsell, D.S., Huey, R. & Olson, A.J. 1996. Distributed automated docking of flexible ligands - to proteins: Parallel applications of AutoDock 2.4. Journal of Computer-Aided Molecular Design 10(4): 293-304.

Peers, E., Bosch, X., Kaldor, J., Linsell, A. & Pluumen, M. 1987. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. International Journal of Cancer 39(5): 545-553.

Peers, E. & Linsell, C.A. 1973. Dietary aflatoxins and liver cancer-a population based study in Kenya. British Journal of Cancer 27(6): 473-483.

Phongdara, A., Nakkaew, A. & Nualkaew, S. 2012. Isolation of the detoxification enzyme EgP450 from an oil palm EST library. Pharmaceutical Biology 50(1): 120-127.

Portman, R.S., Plowman, K.M. & Campbell, T.C. 1970. On mechanisms affecting species susceptibility to aflatoxin. Biochimica et Biophysica Acta 208(3): 487-495.

Ramsdell, H.S., Parkinson, A., Eddy, A.C. & Eaton, D.L. 1991. Bioactivation of aflatoxin B1 by human liver microsomes: Role of cytochrome P450 IIIA enzymes. Toxicology and Applied Pharmacology 108(3): 436-447.

Raney, K.D., Shimada, T., Kim, D-H., Groopman, J.D., Harris, T.M. & Guengerich, F.P. 1992. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: Significance of aflatoxin-Q1 as a detoxication product of aflatoxin-B1. Chemical Research in Toxicology 5(2): 202-210.

Shimada, T. & Guengedch, E.E. 1989. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proceedings of the National Academy of Sciences 86(2): 462-465.

Song, L.B., Zeng, M.S., Liao, W.T., Zhang, L., Mo, H.Y., Liu, W.L., Shao, J.Y., Wu, Q.L., Li, M.Z., Xia, Y.F., Fu, L.W., Huang, W.L., Dimri, G.P., Band, V. & Zeng, Y.X. 2006. Bmi- 1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Research 66(12): 6225-6232.

Vesselinovitch, S.D., Mihailovich, N., Wogan, G.N., Lombard, L.S. & Rao, K.V.N. 1972. Aflatoxin B1, a hepatocarcinogen in the infant mouse. Cancer Research 32: 2289-2291.

Vieira, P.M., Francisco, A.F., Souza, S.M., Malaquias, L.C., Reis, A.B., Giunchetti, R.C., Veloso, V.M., de Lana, M., Tafuri, W.L. & Carneiro, C.M. 2009. Trypanosoma cruzi: Serum levels of nitric oxide and expression of inducible nitric oxide synthase in myocardium and spleen of dogs in the acute stage of infection with metacyclic or blood trypomastigotes. Experimental Parasitology 121(1): 76-82.

Wogan, G.N. 1973. Host environment interactions in the etiology of cancer in man. Cancer Research 7: 237-241.

 

*Corresponding author; email: pamornra@yahoo.com